- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04578184
Epithelial Thickness Map
Comparison of Two Optical Coherence Tomography Devices in Corneal Epithelial Thickness Maps
In keratoconic eyes, the corneal epithelium shows a localized thinning over the cone that is surrounded by an annulus of epithelial thickening. It has been postulated that epithelial thickness mapping can be a sensitive tool for the keratoconus diagnosis. In keratoconus screening the 5 mm diameter of the corneal centrum may be sufficient while studies have shown that the cone apex is located in this area.
Aim of this study is to assess agreement and repeatability of epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
Secondary objective is to evaluate the differences between healthy and keratoconus eyes using epithelial thickness map data.
This is a prospective monocentric study that includes patients divided into two groups: patients with keratoconus and a control group formed out of patients without corneal pathologies. For each patient only one eye will be included and corneal measurements will be performed, focused on the corneal epithelium thickness.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In total 50 eyes of 50 patients will be included, divided into two groups: study group comprised of 20 eyes with diagnosed keratoconus and a control group formed out of 30 healthy eyes.
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation. After each measurement patients will be asked to blink in order to allow adequate tear-film recovery. Each patient will be measured three times with both devices. Only one visit will be necessary.
The order in which the measurements will be performed (Anterion or MS-39) will be randomised using randomised.org.
The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
Main outcome variable:
- Mean differences in central corneal epithelial thickness between the devices investigated (+ limits of agreement (1.96xSD) between the investigated devices)
Secondary outcome variables:
- Repeatability coefficient (within subject standard deviation - SD) and coefficient of variation of the two devices
- Comparison in epithelial thickness between normal and keratoconus eyes
- Sensitivity and specificity of swept-source OCT device in keratoconus diagnosis
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Oliver Findl, Prof., MD
- Phone Number: +43 1 91021-84611
- Email: hkh.augen.abt@wgkk.at
Study Contact Backup
- Name: Nino Hirnschall, MD, PhD
- Phone Number: +43 1 91021 57564
- Email: office@viros.at
Study Locations
-
-
-
Vienna, Austria, 1140
- Recruiting
- Hanusch Hospital, Ophthalmology department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient with diagnosed keratoconus (diagnosed using tomography and topography map changes and slit-lamp changes) and patients with healthy cornea
- Age 21 and older
- Signed informed consent
Exclusion Criteria:
- Previous ocular surgery
- Associated corneal pathologies (e.g. trauma, edema, scarring)
- In women of childbearing age, a pregnancy test will be performed before inclusion into the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Epithelial thickness map evaluation in keratoconus patients
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices.
The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
|
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
|
OTHER: Epithelial thickness map evaluation in healthy cornea patients
Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices.
The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.
|
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Agreement between two ss-OCT devices in corneal epithelial thickness measurements (LoA in micrometer)
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Repeatability between two ss-OCT devices in corneal epithelial thickness measurements (determination of within-subject standard deviation and Coefficient of variation)
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Oliver Findl, Prof., MD, Head of Department of Ophthalmology, Professor, Principal Investigator
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Epithelial thickness map
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Tianjin Eye HospitalActive, not recruitingScansys, Pentacam, Corvis ST, Keratoconus, Subclinical KeratoconusChina
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Kent Wellish MDNot yet recruitingKeratoconus, Unstable
-
Kasr El Aini HospitalUnknownProgressive KeratoconusEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedProgressive Keratoconus
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Tianjin Eye HospitalCompletedKeratoconus, StableChina
Clinical Trials on Corneal epithelial thickness measurements
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Batman Training and Research HospitalCompletedMacula Edema | Menopause Surgical | Visual Acuity Reduced TransientlyTurkey
-
Wroclaw Medical UniversityCompleted
-
Marmara UniversityCompletedBreast Cancer | Lymphedema of Upper ArmTurkey
-
Wenzhou Medical UniversityCompletedMicrocornea Within One Year of AgeChina
-
Bambino Gesù Hospital and Research InstituteCompleted
-
Universidad Complutense de MadridOsteology FoundationRecruiting
-
Chunxiao WangCompleted